文献速递银屑病与炎症性皮肤病

角质形成细胞中DLX3依赖的STAT3信号调控皮肤免疫稳态

DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis.
PubMed 文献 · J Invest Dermatol · 2017-12-12

本研究通过他莫昔芬诱导的Krt14-cre/ERT系统在成年小鼠表皮急性敲除DLX3,发现3天内出现分化相关基因表达异常、促炎细胞因子上调及朗格汉斯细胞和巨噬细胞积聚;1周后IL-17A分泌性Vγ4 γδ T细胞积聚及IL-17和IL-36家族细胞因子水平升高。转录组分析显示STAT3信号激活,局部使用STAT3激活抑制剂可减轻免疫表型,表明DLX3是维持皮肤稳态的STAT3信号网络关键调控因子。

要点

  • 表皮DLX3缺失3天内即引起分化基因异常和炎症细胞积聚。
  • DLX3缺失1周后出现IL-17A分泌性Vγ4 γδ T细胞及IL-17/IL-36升高。
  • 局部STAT3抑制剂可减轻DLX3缺失诱导的免疫表型。

核心结论

  • DLX3是维持皮肤稳态的STAT3信号网络关键调控因子,其缺失通过STAT3依赖途径驱动IL-17相关银屑病样炎症。

研究设计与样本

  • 采用他莫昔芬诱导的Krt14-cre/ERT系统在成年小鼠表皮急性敲除DLX3,并对K14CreERT;DLX3fl/fl皮肤进行转录组和RNA-seq分析。

主要发现

  • DLX3敲除3天内出现分化相关基因表达异常、促炎细胞因子上调及朗格汉斯细胞和巨噬细胞积聚。
  • DLX3敲除1周后IL-17A分泌性Vγ4 γδ T细胞积聚增加,IL-17和IL-36家族细胞因子水平升高。
  • 3天时转录组分析鉴定STAT3为激活的转录调节因子,STAT3信号相关基因差异表达。
  • K14CreERT;DLX3fl/fl皮肤中STAT3激活显著增加,局部STAT3激活抑制剂减轻免疫表型。
  • RNA-seq分析显示STAT3抑制剂处理与白细胞浸润抑制相关基因差异表达。

临床怎么用

  • 提示STAT3信号通路可能作为DLX3缺失相关IL-17型皮肤炎症的干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidermal-specific deletion of the homeobox transcription regulator DLX3 disrupts keratinocyte differentiation and results in an IL-17-linked psoriasis-like skin inflammation. To identify the epidermal initiating signals produced by DLX3-null keratinocytes, we performed acute deletion of DLX3 in adult epidermis using a tamoxifen-inducible Krt14-cre/ERT system. K14CreERT;DLX3fl/fl skin exhibited dysregulated expression of differentiation-associated genes, upregulation of proinflammatory cytokines, and accumulation of Langerhans cells and macrophages within 3 days of tamoxifen-induced DLX3 ablation. We also observed increased accumulation of IL-17A-secreting Vγ4 γδ T cells and heightened levels of IL-17 and IL-36 family of cytokines starting 1 week after DLX3 deletion. Interestingly, transcriptome profiling of K14CreERT;DLX3fl/fl epidermis at 3 days identified activated STAT3 as a transcriptional regulator and revealed differential expression of STAT3 signaling-related genes. Furthermore, activation of STAT3 was strongly increased in K14CreERT;DLX3fl/fl skin, and topical treatment with an inhibitor of STAT3 activation attenuated the immune phenotype. RNA-seq analysis of vehicle and STAT3 inhibitor treated K14CreERT;DLX3fl/fl skin identified differentially expressed genes associated with inhibition of leukocyte infiltration. Collectively, our results show that DLX3 is a critical regulator of STAT3 signaling network that maintains skin homeostasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Bhattacharya S, Kim JC, Ogawa Y, et al. DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis. J Invest Dermatol. 2017. PMID: 29246798. doi:10.1016/j.jid.2017.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。